Drugs / Trappsol (R) Cyclo (TM)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03624842 | — | Alzheimer disease 2 | Cyclo Therapeutics, Inc. | No longer available | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trappsol (R) Cyclo (TM) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03624842 ↗ |
| Route | Intravenous | “Trappsol(R) Cyclo(TM) will be administered via intravenous (IV) infusion.” NCT03624842 ↗ |